The Need for Separate Performance Goals for Glucose Sensors in the Hypoglycemic, Normoglycemic, and Hyperglycemic Ranges

Klonoff, David C.
March 2004
Diabetes Care;Mar2004, Vol. 27 Issue 3, p834
Academic Journal
Assesses the significance of the blood glucose monitors in determining the physiological status of various diabetic patients. Risks of an acute brain damage; Causes of hypoglycemia; Analysis on the blood samples of the patients.


Related Articles

  • Hypoglycemia: What Do You Feel In Your Body? What Do You Feel In Your Mind? King, Scott // Diabetes Health;Jun/Jul2008, Vol. 17 Issue 3, p8 

    The article offers information on hypoglycemia. The author claims that hypoglycemia has become a major concern for diabetics because severe attacks might lead to brain damage, coma or death. There are two symptoms associated with hypoglycemia, the neurogenic symptoms that affect the patient's...

  • neonatal hypoglycaemia. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p535 

    An encyclopedia entry for "neonatal hypoglycaemia" is presented. It refers to an abnormally low blood glucose level found in infants under four weeks of age. Commonly caused by diabetes mellitus in pregnant mothers, the condition may result in permanent brain damage. Among its symptoms are...

  • Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors. Kovatchev, Boris P.; Gonder-Frederick, Linda A.; Cox, Daniel J.; Clarke, William L. // Diabetes Care;Aug2004, Vol. 27 Issue 8, p1922 

    OBJECTIVE — The objective of this study was to introduce continuous glucose- error grid analysis (CG-EGA) as a method of evaluating the accuracy of continuous glucose-monitoring sensors in terms of both accurate blood glucose (BG) values and accurate direction and rate of BG fluctuations...

  • Dynamical glucometry: Use of multiscale entropy analysis in diabetes. Costa, Madalena D.; Henriques, Teresa; Munshi, Medha N.; Sega, Alissa R.; Goldberger, Ary L. // Chaos;Sep2014, Vol. 24 Issue 3, p1 

    Diabetes mellitus (DM) is one of the world's most prevalent medical conditions. Contemporary management focuses on lowering mean blood glucose values toward a normal range, but largely ignores the dynamics of glucose fluctuations. We probed analyte time series obtained from continuous glucose...

  • Hypoglycaemia and the neonatal brain. Hawdon, J. M. // European Journal of Pediatrics;1999, Vol. 158 Issue 13, pS9 

    Abstract There has been much controversy and confusion regarding potential damage caused to the neonatal brain by low blood glucose levels. Previous studies of outcome after neonatal hypoglycaemia are flawed by many factors including retrospective data collection and inability to control for...

  • Blood glucose monitoring.  // Update;11/18/2004, Vol. 69 Issue 7, p244 

    The article provides information that in a number of primary care trusts(PCT), the cost of blood glucose strips is greater than that of insulin, so some PCT are reported to be trying to limit the number of testing strips that could be prescribed. A recent BMJ editorial on this subject has...

  • Improving Epinephrine Responses in Hypoglycemia Unawareness With Real-Time Continuous Glucose Monitoring in Adolescents With Type 1 Diabetes. LY, TRANG T.; HEWITT, JACQUELINE; DAVEY, RAYMOND J.; LIM, EE MUN; DAVIS, ELIZABETH A.; JONES, TIMOTHY W. // Diabetes Care;Jan2011, Vol. 34 Issue 1, p50 

    OBJECTIVE -- To determine whether real-time continuous glucose monitoring (CGM) with preset alarms at specific glucose levels would prove a useful tool to achieve avoidance of hypoglycemia and improve the counterregulatory response to hypoglycemia in adolescents with type 1 diabetes with...

  • Failure to Wake in Response to Hypoglycemia after Juvenile Recurrent Hypoglycemia in Rats. Tkacs, Nancy C.; Pan, Yanhua; Morrison, Adrian R. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA101 

    Nocturnal hypoglycemia that fails to result in arousal from sleep is common in children, adolescents, and adults with type 1 diabetes mellitus. Recurrent nocturnal hypoglycemia contributes to and sustains hypoglycemia-associated autonomic failure. We tested the ability of three episodes of...

  • A Comparison of Pharmocodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 & Pure Insulin Aspart in Type 1 Diabetes. Thorisdottir, Rannveig L.; Parkner, Tina; Jian-Wen Chen; Ejskjær, Niels; Christiansen, Jens S. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA555 

    Studies comparing the clinical pharmacological characteristics of different formulations of an insulin analogue are few. We investigated the pharmacokinetic and pharmacodynamic profiles of four different formulations of the aspart insulin analogue: Pure Insulin Aspart (IAsp), Biphasic Insulin...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics